Biotechnology Clinical Trials Coronavirus Coronavirus COVID-19 Infectious Diseases rare diseases Lilly announces proof of concept data for neutralizing antibody LY-CoV555 in the COVID-19 outpatient setting By Staff Reports 7 months ago Eli Lilly and Company said proof of concept data from an interim analysis of the
Biotechnology cancer CU Researchers Come Together to Better Understand Ovarian Cancer Tumors and Treatment Outcomes By Staff Reports 7 months ago After nearly four years of work, a group of researchers and clinicians from the University
Biotechnology Centers for Disease Control Clinical Trials Coronavirus Coronavirus COVID-19 Infection Control Infectious Diseases rare diseases Vaccines Antibody responses in COVID-19 patients could guide vaccine design By Staff Reports 7 months ago A comprehensive analysis of antibody responses in coronavirus disease 2019 (COVID-19) patients could inform the
Biotechnology Breast Cancer cancer Clinical Trials Scientists Identify New Way To Target Some Rapidly Dividing Cancer Cells, Leaving Healthy Cells Unharmed By Staff Reports 7 months ago Scientists at Johns Hopkins Medicine and the University of Oxford say they have found a
Coronavirus COVID-19 Small Study Shows Convalescent Plasma is Safe to Use in Pediatric Patients with COVID-19 By Staff Reports 7 months ago Early findings from researchers at Children’s Hospital of Philadelphia (CHOP)show that convalescent plasma appears to be
Coronavirus COVID-19 AstraZeneca COVID-19 vaccine study halted after ‘potentially unexplained’ illness By Staff Reports 7 months ago (AP) Late-stage studies of AstraZeneca’s COVID-19 vaccine candidate are on temporary hold while the company
cancer Innovative, minimally invasive treatment can help maintain prostate cancer patients’ quality of life By Staff Reports 7 months ago For some prostate cancer patients, radical treatment (surgery or radiation) are treatment standards. However, these
Coronavirus COVID-19 Obese patients at high risk of severe COVID-19 illness, study finds By Staff Reports 8 months ago BLOOMBERG — Obese and overweight people are at high risk of suffering severe cases of
Biotechnology Clinical Trials Coronavirus Coronavirus COVID-19 rare diseases Vaccines Preclinical study of COVID-19 vaccine candidate shows potent T-cell responses By Staff Reports 8 months ago Preclinical studies of a COVID-19 vaccine candidate at the University of Alabama at Birmingham show
Biotechnology cancer Clinical Trials drug development New Treatment Developed by Children’s Hospital of Philadelphia Shows Success in High-Risk Solid Tumors By Staff Reports 8 months ago Despite intensive treatment, high-risk solid tumors like neuroblastoma, Ewing sarcoma, and rhabdomyosarcoma are challenging to
Biotechnology cancer Clinical Trials Targeted therapy combination effective for patients with advanced cholangiocarcinoma and BRAF mutations By Staff Reports 8 months ago In a Phase II trial led by researchers at The University of Texas MD Anderson
Uncategorized Breakthrough led by NUS researchers provides new potential therapies for osteoporosis By Staff Reports 8 months ago A research team from the National University of Singapore (NUS) has identified a new avenue
Biotechnology Coronavirus Coronavirus COVID-19 drug development UCI scientists get ‘initial hit’ in developing drug to treat COVID-19 By Staff Reports 8 months ago When the coronavirus pandemic hit, almost everyone at the University of California, Irvine – and
Biotech Company News Biotechnology Clinical Trials Coronavirus Coronavirus COVID-19 Vaccines CEL-SCI Announced Early Results with COVID 19 LEAPS Vaccine/Treatment By Staff Reports 9 months ago CEL-SCI Corporation announces that it has concluded animal experiments using its LEAPS COVID 19 conjugate
Biotechnology Coronavirus Coronavirus COVID-19 COVID-19: Patients Improve After Immune-Suppressant Treatment By Staff Reports 9 months ago Most patients hospitalized with COVID-19 (coronavirus) pneumonia experienced improvement after receiving a Food and Drug
Coronavirus COVID-19 Moderna’s Coronavirus Vaccine shows ‘Promising’ Safety and Immune response results in Published Phase 1 Study By Staff Reports 9 months ago A Covid-19 vaccine developed by the biotechnology company Moderna in partnership with the National Institutes of Health
Biotechnology genes Ophthalmology Scientists Use Nanoparticle-Delivered Gene Therapy to Inhibit Blinding Eye Disease in Rodents By Staff Reports 9 months ago In experiments in rats and mice, two Johns Hopkins scientists — an engineer and an
Coronavirus Coronavirus COVID-19 rare diseases COVID-19 Fatality Risk Is Double Earlier Estimates By Staff Reports 10 months ago In one of the most robust studies of COVID-19 mortality risk in the United States,
Biotechnology Neurodegenerative diseases Neurology Neuroscience Parkinson's Novel pathology could improve diagnosis and treatment of Huntington’s and other diseases By Staff Reports 10 months ago Bristol scientists have discovered a novel pathology that occurs in several human neurodegenerative diseases, including
Coronavirus COVID-19 How COVID-19 affects Pediatric Patients By Staff Reports 10 months ago New insights into the clinical and epidemiological characteristics of pediatric patients with coronavirus disease 2019